Bahar ME, Kim HJ, Kim DR (2023) Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct Target Ther 8:455

CAS  PubMed  PubMed Central  Google Scholar 

Bridgewater J, Galle PR, Khan SA, Llovet JM, Park J-W, Patel T, Pawlik TM, Gores GJ (2014) Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 60:1268–1289

PubMed  Google Scholar 

Chen XQ, Chen JG, Zhang Y, Hsiao WWL, Yu ACH (2003) 14-3-3gamma is upregulated by in vitro ischemia and binds to protein kinase Raf in primary cultures of astrocytes. Glia 42:315–324

CAS  PubMed  Google Scholar 

Chen K, Zhang J, Beeraka NM, Li J, Sinelnikov MY, Zhang X, Cao Y, Zakharova DK, Nikolenko VN, Reshetov IV et al (2023) Novel perspectives on Nanotechnological and biomedical implications of monotherapy or combination regimen of lactoferrin. Curr Pharm Des 29:1579–1591

CAS  PubMed  Google Scholar 

Hammond SM (2015) An overview of MicroRNAs. Adv Drug Deliv Rev 87

Ilyas SI, Gores GJ (2013) Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology 145:1215–1229

PubMed  Google Scholar 

Ilyas SI, Khan SA, Hallemeier CL, Kelley RK, Gores GJ (2018) Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol 15

Kam AE, Masood A, Shroff RT (2021) Current and emerging therapies for advanced biliary tract cancers. Lancet Gastroenterol Hepatol 6:956–969

PubMed  Google Scholar 

Kara G, Calin GA, Ozpolat B (2022) RNAi-based therapeutics and tumor targeted delivery in cancer. Adv Drug Deliv Rev 182:114113

CAS  PubMed  Google Scholar 

Khan AS, Dageforde LA (2019) Cholangiocarcinoma Surg Clin North Am 99:315–335

PubMed  Google Scholar 

Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J (2019) The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet 20:675–691

CAS  PubMed  Google Scholar 

Kristensen LS, Jakobsen T, Hager H, Kjems J (2022) The emerging roles of circrnas in cancer and oncology. Nat Rev Clin Oncol 19:188–206

CAS  PubMed  Google Scholar 

Lavoie H, Gagnon J, Therrien M (2020) ERK signalling: a master regulator of cell behaviour, life and fate. Nat Rev Mol Cell Biol 21:607–632

CAS  PubMed  Google Scholar 

Liao W, Feng Q, Liu H, Du J, Chen X, Zeng Y (2023) Circular RNAs in cholangiocarcinoma. Cancer Lett 553, 215980

Moris D, Palta M, Kim C, Allen PJ, Morse MA, Lidsky ME (2023) Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians. CA Cancer J Clin 73:198–222

PubMed  Google Scholar 

Morrison DK (2009) The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol 19:16–23

CAS  PubMed  Google Scholar 

Ni J, Wang J, Fu Y, Yan C, Zhu M, Jiang Y, Chen J, Ding Y, Fan X, Li G et al (2020) Functional genetic variants in centrosome-related genes CEP72 and YWHAG confer susceptibility to gastric cancer. Arch Toxicol 94:2861–2872

CAS  PubMed  Google Scholar 

Pei Y, Zhang H, Lu K, Tang X, Li J, Zhang E, Zhang J, Huang Y, Yang Z, Lu Z et al (2022) Circular RNA circrna_0067934 promotes glioma development by modulating the MicroRNA miR-7/ Wnt/β-catenin axis. Bioengineered 13:5792–5802

CAS  PubMed  PubMed Central  Google Scholar 

Rupaimoole R, Slack FJ (2017) MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov 16:203–222

CAS  PubMed  Google Scholar 

Saliminejad K, Khorshid K, Fard HRS, S., and, Ghaffari SH (2019) An overview of micrornas: biology, functions, therapeutics, and analysis methods. J Cell Physiol 234:5451–5465

CAS  PubMed  Google Scholar 

Samatar AA, Poulikakos PI (2014) Targeting RAS-ERK signalling in cancer: promises and challenges. Nat Rev Drug Discov 13:928–942

CAS  PubMed  Google Scholar 

Shi A, Liu Z, Fan Z, Li K, Liu X, Tang Y, Hu J, Li X, Shu L, Zhao L et al (2024) Function of mast cell and bile-cholangiocarcinoma interplay in cholangiocarcinoma microenvironment. Gut 73:1350–1363

CAS  PubMed  Google Scholar 

Shu L, Li X, Liu Z, Li K, Shi A, Tang Y, Zhao L, Huang L, Zhang Z, Zhang D et al (2024) Bile Exosomal miR-182/183-5p increases cholangiocarcinoma stemness and progression by targeting HPGD and increasing PGE2 generation. Hepatology (Baltimore MD) 79:307–322

PubMed  Google Scholar 

Su Q, Lv X (2020) Revealing new landscape of cardiovascular disease through circular RNA-miRNA-mRNA axis. Genomics 112:1680–1685

CAS  PubMed  Google Scholar 

Sun J-Y, Zhang X-Y, Cao Y-Z, Zhou X, Gu J, Mu X-X (2020) Diagnostic and prognostic value of circular RNAs in hepatocellular carcinoma. J Cell Mol Med 24:5438–5445

CAS  PubMed  PubMed Central  Google Scholar 

Tan W, Liu B, Qu S, Liang G, Luo W, Gong C (2018) MicroRNAs and cancer: key paradigms in molecular therapy. Oncol Lett 15:2735–2742

PubMed  Google Scholar 

Tang Y, Xu L, Zhang G, Li K, Shi A, Shu L, Zhao L, Li E, Sun K, Pan G et al (2024) Survival analysis and prognostic nomogram for patients with cholangiocarcinoma after radical resection in Asia. Eur J Surg Oncol 50:108659

PubMed  Google Scholar 

Tang Y, Yuan F, Cao M, Ren Y, Li Y, Yang G, Zhong Z, Liang H, Xiong Z, He Z et al (2025) CircRNA-mTOR promotes hepatocellular carcinoma progression and lenvatinib resistance through the PSIP1/c-Myc Axis. Advanced science. Weinheim, Baden-Wurttemberg, Germany, p e2410591

Google Scholar 

Ullah R, Yin Q, Snell AH, Wan L (2022) RAF-MEK-ERK pathway in cancer evolution and treatment. Semin Cancer Biol 85:123–154

CAS  PubMed  Google Scholar 

Xu J, Wang J, He Z, Chen P, Jiang X, Chen Y, Liu X, Jiang J (2021) LncRNA CERS6-AS1 promotes proliferation and metastasis through the upregulation of YWHAG and activation of ERK signaling in pancreatic cancer. Cell Death Dis 12:648

CAS  PubMed  PubMed Central  Google Scholar 

Xue C, Li G, Zheng Q, Gu X, Bao Z, Lu J, Li L (2022) The functional roles of the circrna/wnt axis in cancer. Mol Cancer 21:108

CAS  PubMed  PubMed Central  Google Scholar 

Yuan W, Peng S, Wang J, Wei C, Ye Z, Wang Y, Wang M, Xu H, Jiang S, Sun D et al (2019) Identification and characterization of circrnas as competing endogenous RNAs for miRNA-mRNA in colorectal cancer. PeerJ 7:e7602

PubMed  PubMed Central  Google Scholar 

Yuan F, Tang Y, Liang H, Cao M, Ren Y, Li Y, Yang G, Zhong Z, Xiong Z, He Z et al (2025) CircPIK3C3 inhibits hepatocellular carcinoma progression and lenvatinib resistance by suppressing the Wnt/β-catenin pathway via the miR-452-5p/SOX15 axis. Genomics 117:110999

CAS  PubMed  Google Scholar 

Zhang Z, Yang T, Xiao J (2018) Circular rnas: promising biomarkers for human diseases. 34:267–274

Zhao W, Dong M, Pan J, Wang Y, Zhou J, Ma J, Liu S (2019) Circular rnas: A novel target among non–coding RNAs with potential roles in malignant tumors (Review). Mol Med Rep 20:3463–3474

CAS  PubMed  PubMed Central  Google Scholar 

Zhao L, Liu J, Li K, Zhang C, Chen T, Liu Z, Tang Y, Hu X, Shi A, Shu L et al (2024) PTPN9 dephosphorylates FGFR2 pY656/657 through interaction with ACAP1 and ameliorates Pemigatinib effect in cholangiocarcinoma. Hepatology (Baltimore MD) 79:798–812

PubMed  Google Scholar 

Zhou W-Y, Cai Z-R, Liu J, Wang D-S, Ju H-Q, Xu R-H (2020) Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer 19:172

CAS  PubMed  PubMed Central  Google Scholar